Assessment of the Effect of the Product RV2666C Formula LA2984 Compared to an Untreated Area With an Epidermally Ablated Skin Model Obtained With an Erbium YAG Laser on Adults Presenting IV to VI Skin Phototype
- Conditions
- Healthy
- Registration Number
- NCT07166484
- Lead Sponsor
- Pierre Fabre Dermo Cosmetique
- Brief Summary
In this study, we assess the efficacy of a cosmetic product in adults with IV to VI skin phototype.
This study is conducted as a monocentric, controlled, compared with an untreated area and randomized for the area of product application.
To perform this clinical study, minimum 20 - maximum 24 subjects (man or woman), aged from 18 to 50 years are enrolled.
The subjects applied the investigational product on an area located on the anterior side of the forearm, following the laser YAG act, once a day and under occlusion from Day 1 to Day 3 included. Then it is applied twice a day in an open way from Day 4 until Day 18 included.
10 visits are planned:
* Visit 1: Inclusion visit = Day 1
* Visit 2 to Visit 5: Intermediate visits = Day 2 to Day 5
* Visit 6: Intermediate visit = Day 8
* Visit 7: Intermediate visit = Day 10
* Visit 8: Intermediate visit = Day 12
* Visit 9: Intermediate visit = Day 15
* Visit 10: End of study visit = Day 19-1
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 24
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time to complete wound healing Day 1 - Visit 1, Day 2 - Visit 2, Day 3 - Visit 3, Day 4 - Visit 4, Day 5 - Visit 5, Day 8 - Visit 6, Day 10 - Visit 7, Day 12 - Visit 8, Day 15 - Visit 9 and Day 19 - Visit 10. The wound disappearance is assessed by the investigator by clinical exam of the skin and from standardized photographs taken with a C Cube Caméra©.
The erythema of the skin Day 1 - Visit 1 (before and after laser YAG act), Day 2 - Visit 2, Day 3 - Visit 3, Day 4 - Visit 4, Day 5 - Visit 5, Day 8 - Visit 6, Day 10 - Visit 7, Day 12 - Visit 8, Day 15 - Visit 9 and Day 19 - Visit 10. The erythema of the skin is assessed objectively using treatment software from standardized photographs using a C Cube Camera©.
The pigmentation of the skin Day 1 - Visit 1 (before and after laser YAG act), Day 2 - Visit 2, Day 3 - Visit 3, Day 4 - Visit 4, Day 5 - Visit 5, Day 8 - Visit 6, Day 10 - Visit 7, Day 12 - Visit 8, Day 15 - Visit 9 and Day 19 - Visit 10. The pigmentation of the skin is assessed objectively using treatment software from standardized photographs using a C Cube Camera©.
The skin marks Day 2 - Visit 2, Day 3 - Visit 3, Day 4 - Visit 4, Day 5 - Visit 5, Day 8 - Visit 6, Day 10 - Visit 7, Day 12 - Visit 8, Day 15 - Visit 9 and Day 19 - Visit 10. The skin marks are evaluated by the investigator at the end of the study using standardized photographs taken with a C Cube© Camera and using an NRS-type evaluation scale from 0 to 10.
The wound healing quality Day 8 - Visit 6, Day 10 - Visit 7, Day 12 - Visit 8, Day 15 - Visit 9 and Day 19 - Visit 10. The wound healing quality is evaluated by the investigator at the end of the study using standardized photographs taken with a C Cube© Camera and using an NRS-type evaluation scale from 0 to 10.
The global efficacy of the product Day 19 - Visit 10 The global efficacy of the product is assessed by the subject with a 7-questions questionnaire.
The transepidermal water loss Day 1 - Visit 1 (before and after laser YAG act), Day 2 - Visit 2, Day 3 - Visit 3, Day 4 - Visit 4, Day 5 - Visit 5, Day 8 - Visit 6, Day 10 - Visit 7, Day 12 - Visit 8, Day 15 - Visit 9 and Day 19 - Visit 10. The transepidermal water loss is measured by a clinical research technician using a Vapometer©.
Standardized photographs in an illustrative purpose Day 1 - Visit 1 (before and after laser YAG act), Day 2 - Visit 2, Day 3 - Visit 3, Day 4 - Visit 4, Day 5 - Visit 5, Day 8 - Visit 6, Day 10 - Visit 7, Day 12 - Visit 8, Day 15 - Visit 9 and Day 19 - Visit 10. Photographs in 2D and 3D are taken using a C Cube Camera©.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Skin Research Center
🇫🇷Toulouse, France, France
Skin Research Center🇫🇷Toulouse, France, FranceJennifer TheunisPrincipal Investigator